Schedule 13G ownership disclosure
Cytek Biosciences Inc
Security class unavailable · CUSIP: 23285D109
Event date: 2022-08-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.2300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-22-021197
- Form type
- SC 13G
- Filer
- 3E Bioventures Capital, L.P.
- CIK
- CIK 1911673
- Filed
- Aug 03, 2022
- Reporting period
- Aug 03, 2022
- Description
- Schedule 13G beneficial ownership